# Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors

> **NCT05959395** · NA · UNKNOWN · sponsor: **NeoTherma Oncology** · enrollment: 5 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DEVICE:** VectRx Thermal Therapy

## Key facts

- **NCT ID:** NCT05959395
- **Lead sponsor:** NeoTherma Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-15
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-04-30
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959395, "Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05959395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*